Targeting the I Channel PKA Phosphorylation Axis to Restore Its Function in High-Risk LQT1 Variants

Overview

Journal Circ Res

Specialty Cardiology & Vascular Diseases

Date 2024 Aug 21

PMID 39166328

Authors

Ling Zhong

Zhenzhen Yan

Dexiang Jiang

Kuo-Chan Weng

Yue Ouyang

Hangyu Zhang

XiaoQing Lin

Chenxin Xiao

Huaiyu Yang

Jing Yao

Xinjiang Kang

Changhe Wang

Chen Huang

Bing Shen

Sookja Kim Chung

Zhi-Hong Jiang

Wandi Zhu

Erwin Neher

Jonathan R Silva

Panpan Hou

Affiliations

Soon will be listed here.

Abstract

Background: The KCNQ1+KCNE1 (I) potassium channel plays a crucial role in cardiac adaptation to stress, in which β-adrenergic stimulation phosphorylates the I channel through the cyclic adenosine monophosphate (cAMP)/PKA (protein kinase A) pathway. Phosphorylation increases the channel current and accelerates repolarization to adapt to an increased heart rate. Variants in KCNQ1 can cause long-QT syndrome type 1 (LQT1), and those with defective cAMP effects predispose patients to the highest risk of cardiac arrest and sudden death. However, the molecular connection between I channel phosphorylation and channel function, as well as why high-risk LQT1 mutations lose cAMP sensitivity, remain unclear.

Methods: Regular patch clamp and voltage clamp fluorometry techniques were utilized to record pore opening and voltage sensor movement of wild-type and mutant KCNQ1/I channels. The clinical phenotypic penetrance of each LQT1 mutation was analyzed as a metric for assessing their clinical risk. The patient-specific-induced pluripotent stem-cell model was used to test mechanistic findings in physiological conditions.

Results: By systematically elucidating mechanisms of a series of LQT1 variants that lack cAMP sensitivity, we identified molecular determinants of I channel regulation by phosphorylation. These key residues are distributed across the N-terminus of KCNQ1 extending to the central pore region of I. We refer to this pattern as the I channel PKA phosphorylation axis. Next, by examining LQT1 variants from clinical databases containing 10 579 LQT1 carriers, we found that the distribution of the most high-penetrance LQT1 variants extends across the I channel PKA phosphorylation axis, demonstrating its clinical relevance. Furthermore, we found that a small molecule, ML277, which binds at the center of the phosphorylation axis, rescues the defective cAMP effects of multiple high-risk LQT1 variants. This finding was then tested in high-risk patient-specific induced pluripotent stem cell-derived cardiomyocytes, where ML277 remarkably alleviates the beating abnormalities.

Conclusions: Our findings not only elucidate the molecular mechanism of PKA-dependent I channel phosphorylation but also provide an effective antiarrhythmic strategy for patients with high-risk LQT1 variants.

References

Mikuni I, Torres C, Bienengraeber M, Kwok W . Partial restoration of the long QT syndrome associated KCNQ1 A341V mutant by the KCNE1 β-subunit. Biochim Biophys Acta. 2011; 1810(12):1285-93. PMC: 3215802. DOI: 10.1016/j.bbagen.2011.07.018. View

Garg P, Garg V, Shrestha R, Sanguinetti M, Kamp T, Wu J . Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes as Models for Cardiac Channelopathies: A Primer for Non-Electrophysiologists. Circ Res. 2018; 123(2):224-243. PMC: 6136439. DOI: 10.1161/CIRCRESAHA.118.311209. View

Zhang S, Ma D, Wang K, Li Y, Yang Z, Li X . A small-molecule activation mechanism that directly opens the KCNQ2 channel. Nat Chem Biol. 2024; 20(7):847-856. DOI: 10.1038/s41589-023-01515-y. View

Liin S, Barro-Soria R, Larsson H . The KCNQ1 channel - remarkable flexibility in gating allows for functional versatility. J Physiol. 2015; 593(12):2605-15. PMC: 4500346. DOI: 10.1113/jphysiol.2014.287607. View

Eldstrom J, McAfee D, Dou Y, Wang Y, Fedida D . ML277 regulates KCNQ1 single-channel amplitudes and kinetics, modified by voltage sensor state. J Gen Physiol. 2021; 153(12). PMC: 8515649. DOI: 10.1085/jgp.202112969. View

Liin S, Ejneby M, Barro-Soria R, Skarsfeldt M, Larsson J, Starck Harlin F . Polyunsaturated fatty acid analogs act antiarrhythmically on the cardiac IKs channel. Proc Natl Acad Sci U S A. 2015; 112(18):5714-9. PMC: 4426425. DOI: 10.1073/pnas.1503488112. View

Chen H, Kim L, Rajan S, Xu S, Goldstein S . Charybdotoxin binding in the I(Ks) pore demonstrates two MinK subunits in each channel complex. Neuron. 2003; 40(1):15-23. DOI: 10.1016/s0896-6273(03)00570-1. View

Murray C, Westhoff M, Eldstrom J, Thompson E, Emes R, Fedida D . Unnatural amino acid photo-crosslinking of the IKs channel complex demonstrates a KCNE1:KCNQ1 stoichiometry of up to 4:4. Elife. 2016; 5. PMC: 4807126. DOI: 10.7554/eLife.11815. View

Liu Y, Xu X, Gao J, Naffaa M, Liang H, Shi J . A PIP substitute mediates voltage sensor-pore coupling in KCNQ activation. Commun Biol. 2020; 3(1):385. PMC: 7367283. DOI: 10.1038/s42003-020-1104-0. View

10.

Taylor K, Kang P, Hou P, Yang N, Kuenze G, Smith J . Structure and physiological function of the human KCNQ1 channel voltage sensor intermediate state. Elife. 2020; 9. PMC: 7069725. DOI: 10.7554/eLife.53901. View

11.

Hiniesto-Inigo I, Castro-Gonzalez L, Corradi V, Skarsfeldt M, Yazdi S, Lundholm S . Endocannabinoids enhance hK7.1/KCNE1 channel function and shorten the cardiac action potential and QT interval. EBioMedicine. 2023; 89:104459. PMC: 9958262. DOI: 10.1016/j.ebiom.2023.104459. View

12.

Grandi E, Sanguinetti M, Bartos D, Bers D, Chen-Izu Y, Chiamvimonvat N . Potassium channels in the heart: structure, function and regulation. J Physiol. 2016; 595(7):2209-2228. PMC: 5374109. DOI: 10.1113/JP272864. View

13.

Shamgar L, Ma L, Schmitt N, Haitin Y, Peretz A, Wiener R . Calmodulin is essential for cardiac IKS channel gating and assembly: impaired function in long-QT mutations. Circ Res. 2006; 98(8):1055-63. DOI: 10.1161/01.RES.0000218979.40770.69. View

14.

Hou P, Shi J, McFarland White K, Gao Y, Cui J . ML277 specifically enhances the fully activated open state of KCNQ1 by modulating VSD-pore coupling. Elife. 2019; 8. PMC: 6684268. DOI: 10.7554/eLife.48576. View

15.

Osteen J, Gonzalez C, Sampson K, Iyer V, Rebolledo S, Larsson H . KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 channel gate. Proc Natl Acad Sci U S A. 2010; 107(52):22710-5. PMC: 3012494. DOI: 10.1073/pnas.1016300108. View

16.

Hou P, Eldstrom J, Shi J, Zhong L, McFarland K, Gao Y . Inactivation of KCNQ1 potassium channels reveals dynamic coupling between voltage sensing and pore opening. Nat Commun. 2017; 8(1):1730. PMC: 5700111. DOI: 10.1038/s41467-017-01911-8. View

17.

Sun J, MacKinnon R . Cryo-EM Structure of a KCNQ1/CaM Complex Reveals Insights into Congenital Long QT Syndrome. Cell. 2017; 169(6):1042-1050.e9. PMC: 5562354. DOI: 10.1016/j.cell.2017.05.019. View

18.

Yu H, Lin Z, Mattmann M, Zou B, Terrenoire C, Zhang H . Dynamic subunit stoichiometry confers a progressive continuum of pharmacological sensitivity by KCNQ potassium channels. Proc Natl Acad Sci U S A. 2013; 110(21):8732-7. PMC: 3666726. DOI: 10.1073/pnas.1300684110. View

19.

Qi M, Ma S, Liu J, Liu X, Wei J, Lu W . In Vivo Base Editing of Rescues Type 3 Long QT Syndrome in Mice. Circulation. 2023; 149(4):317-329. DOI: 10.1161/CIRCULATIONAHA.123.065624. View

20.

Zou X, Wu X, Sampson K, Colecraft H, Larsson H, Kass R . Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels. Front Physiol. 2022; 13:902224. PMC: 9726718. DOI: 10.3389/fphys.2022.902224. View